Browse > Article

Dosimetric Comparison of Radiation Treatment Techniques for Breast Cancer : 3D-CRT, IMRT and VMAT  

Lee, Bo-Ram (Department of Bio-convergence Engineering, College of Health Science, Korea University)
Lee, Sun-Young (Department of Radiation Oncology, Yusung Sun Medical)
Yoon, Myong-Geun (Department of Bio-convergence Engineering, College of Health Science, Korea University)
Publication Information
Journal of radiological science and technology / v.36, no.3, 2013 , pp. 237-244 More about this Journal
Abstract
The purpose of this study is to compare method in the treatment of breast cancer using dose index. And, it is to find the optimized treatment technique to the patient. The phantom filled with tissue-equivalent material were used simulation and treatment as techniques of 3D-CRT, IMRT, VMAT was planned using Eclipse v10. By using HI(homogeneity index), CI(Conformity index), OED(Organ equivalent dose), EAR(Excess Absolute Risk), were assessed for each treatment plans. HI and CI of 3D-CRT, IMRT, VMAT were calculated 16.89, 11.21, 9.55 and 0.59, 0.61, 0.83. The organ average doses of Lt lung, Rt lung, liver, heart, esophagus, cord, Lt breast, trachea and stomach were 0.01 ~ 2.02 Gy, 0.36 ~ 5.01 Gy, 0.25 ~ 2.49 Gy, 0.14 ~ 6.92 Gy, 0.03 ~ 2.02 Gy, 0.01 ~ 1.06 Gy, 0.25 ~ 6.08 Gy, 0.08 ~ 0.59 Gy, 0.01 ~ 1.34 Gy, respectively. The OED, EAR of the IMRT and VMAT show higher than 3D-CRT. As the result of this study, we could confirm being higher dose index(HI, CI) in IMRT and VMAT than 3D-CRT, but doses of around normal organs was higher IMRT, VMAT than 3D-CRT.
Keywords
Breast cancer; Simulation; Organ Equivalent Dose; Excess Absolute Risk;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Yoon MG, Shin DH, Kim JW, et al. Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photonradiotherapy. Int J Radiat Oncol Biol Phys. 81(3), 637-646, 2011   DOI
2 Schneider U, Kaser-Hotz. Radiation risk estimates after radiotherapy: Application of the organ equivalent dose concept to plateau dose-responserelationships. Radiat Environ Biophys. 44, 235-239, 2005   DOI
3 Wu Q, Mohan R, Morris M, et al. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: Dosimetric results. Int J Radiat Oncol Biol Phys. 56(2), 573- 585, 2003
4 Murthy K, Shukeili K, Kumar S, et al. Evaluation of dose coverage to target volume and normal tissue sparing in the adjuvant radiotherapy of gastric cancers: 3D-CRT compared with dynamic IMRT. Biomed Imaging Interv J. 6(3),e29, 2010
5 Schneider U, Lomax A, Timmermann B. Second cancers in children treated withmodern radiotherapy techniques. Radiother Oncol. 89(2), 135-140, 2008   DOI
6 Verellen D, Vanhavere F. Risk assessment of radiation induced malignancies based on whole-body dose equivalent estimates for IMRT in the head and neck region. Radiother Oncol. 53, 199-203, 1999   DOI
7 Hall EJ, Wuu C. Radiation-induced second cancers: The impact of 3D-CRT andIMRT. Int J Radiat Oncol Biol Phys. 56, 83-88, 2003   DOI
8 Kry SF, Salehpour M, Followill DS, et al. The calculated risk of fatal secondarymalignancies from intensity-modulated radiation therapy. Int J Radiat Oncol BiolPhys. 62, 1195-1203, 2005   DOI
9 Kry SF, Salehpour M, Followill DS, et al. Out-of-field photon and neutron doseequivalents from step-and-shoot intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 62, 1195-1203, 2005   DOI
10 Fontenot J. D, Lee A. K, Newhauser WD. Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stageprostate cancer. Int J Radiat Oncol Biol Phys. 74, 616-622, 2007
11 Hall E. J, Intensity modulated radiation therapy, protons and the risk of secondcancers. Int J Radiat Oncol Biol Phys. 65(1), 1-7, 2006   DOI
12 Followill D, Geis P, Boyer A. Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy. Int J Radiat Oncol Biol Phys. 38, 667-672, 1997   DOI
13 Donovan EM, James H, Bonora M, et al. Second cancer incidence risk estimates using BEIR VII models for standard and complex external beam radiotherapy for early breast cancer. Med Phys. 39(10), 5814-5824, 2012   DOI
14 Schneider U, Walsh L. Cancer risk estimates from the combined JapaneseA-bomb and Hodgkin cohorts for doses relevant to radiotherapy. Radiat Environ Biophys. 47(2), 253-263, 2008   DOI
15 Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958- 1998. Radiat Res. 168, 1-64, 2007   DOI
16 Preston DL, Pierce DA, Shimizu Y, et al. Effects of recent changes in Atomicbomb survivor dosimetry on cancer mortality risk estimated. Radiat Res. 162,377-389, 2004   DOI
17 Walsh L, Ruhm W, Kellerer AM. Cancer risk estimates for X-rays with regard to organ specific doses, part I: all solid cancers combined. Radiat Environ Biophys. 43, 145-151, 2004   DOI
18 Walsh L, Ruhm W, Kellerer AM. Cancer risk estimates for X-rays with regard to organ specific doses, part II: site specific solid cancers. Radiat Environ Biophys. 43, 225-231, 2004   DOI
19 Schneider U, Zwahlen D, Ross D, et al. Estimation of radiation-inducedcancer from three-dimensional dose distributions: Concept of organ equivalent dose. Int J Radiat Oncol Biol Phys. 61(5), 1510-1515, 2005   DOI